Baltimore, MD · Founded 2014 · Privately Held (backing)
Developer of in vitro diagnostic tests designed to aid diagnosis and screening for bacterial and fungal lung infections. Pearl Diagnostics is based in Baltimore, MD and was founded in 2014. Its last reported valuation was $15 million in Jun 2022. It has raised $4.5 million across 2 recorded rounds; the latest was an $11.2 million early-stage round in Mar 2026.
Last reported valuation
$15.0M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
Early Stage VC
Mar 2026
Cap table — not yet on record
Pearl Diagnostics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pearl Diagnostics with a free account
·The complete investor list: 11 names
·Watch Pearl Diagnostics: the Monday email on marks, rounds and moves
Where does Pearl Diagnostics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Pearl Diagnostics's 2 recorded funding rounds.